Activating pharmacists to reduce the frequency of medication-related problems (ACTMed): a stepped wedge cluster randomised trial  Medical Journal of Australia. 2023;219(7):325-331
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37586750

Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes  New England Journal of Medicine. 2023;389(17):1566-1578
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37796241

Cardiovascular disease management in Australian adults with type 2 diabetes: insights from the CAPTURE study  Internal Medicine Journal. 2023;53(10):1796-1805
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36112472

Case Report: Spontaneous Tumor Lysis Syndrome in Untreated Ovarian Cancer  American Journal of Medicine. 2023;136(10):e201
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37356645

Diabetes, prediabetes, and atrial fibrillation-A population-based cohort study based on national and regional registers  Journal of Internal Medicine. 2023;294(5):605-615
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37387643

Growing heart in congenital hypopituitarism treated in adulthood  Lancet. 2023;402(10412):1562-1563
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37898533

Hyperthyroidism: A Review  JAMA. 2023;330(15):1472-1483
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37847271

Hyperthyroidism-induced Cerebral Venous Thrombosis Presenting as Chronic Isolated Intracranial Hypertension  Internal Medicine. 2023;62(20):3021-3025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36792193

Implication of Skeletal Muscle Loss in the Prognosis of Patients with Pancreatic Ductal Adenocarcinoma Receiving Chemotherapy  Internal Medicine. 2023;62(19):2783-2793
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36792197

Incorporating Prognosis into Clinical Decision-Making for Older Adults with Diabetes  Journal of General Internal Medicine. 2023;38(13):2857-2859
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37464148

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial  Lancet. 2023;402(10409):1272-1281
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37708904

The not-so-natural herb: a case of exogenous Cushing syndrome  Medical Journal of Australia. 2023;219(7):297-298
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37658579

A Rare Pancreatic Tumor with Adenomatoid Tumor-like Findings  Internal Medicine. 2023;62(19):2847-2853
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36792192

Reducing Unnecessary Oophorectomies for Benign Ovarian Neoplasms in Pediatric Patients  JAMA. 2023;330(13):1247-1254
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37787794

Reversible Splenial Lesion Triggered by Hyperthyroidism  Internal Medicine. 2023;62(19):2925-2926
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36792190

Semaglutide Associated With Less Insulin Need in Early Type 1 Diabetes  JAMA. 2023;330(14):1318
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37728959

Sodium glucose cotransporter 2 inhibitor-induced ketoacidosis is unlikely in patients without diabetes  Medical Journal of Australia. 2023;219(7):293-294
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37549922

Staying Up Late Tied to Unhealthful Lifestyle, Increased Diabetes Risk  JAMA. 2023;330(14):1319
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37728957

The Syndrome of Inappropriate Antidiuresis  New England Journal of Medicine. 2023;389(16):1499-1509
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37851876

Technology Use and Glycemic Outcomes during Pregnancy with Type 1 Diabetes  New England Journal of Medicine. 2023;389(17):1617-1619
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37796238

Tolerability and efficacy of sodium-glucose co-transporter-2 inhibitors in Australian Aboriginal and Torres Strait Islanders with type 2 diabetes mellitus: an observational study  Internal Medicine Journal. 2023;53(10):1916-1918
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37792407

Type 2 Diabetes - Controlling the Epidemic, Episode 3: Fostering Patient Engagement and Lifestyle Modifications  New England Journal of Medicine. 2023;389(14):e27
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37792611

Type 2 Diabetes - Controlling the Epidemic, Episode 4: Understanding Old and New Therapies for Diabetes  New England Journal of Medicine. 2023;389(16):e31
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37851873

Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin  New England Journal of Medicine. 2023;389(16):1532
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37851882

Willingness to be tested for a secondary cause of hypertension: a survey of the Australian general community  Internal Medicine Journal. 2023;53(10):1826-1836
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=36321804